Form 4 - Statement of changes in beneficial ownership of securities

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hurlburt Elizabeth

(Last)

(First)

(Middle)

C/O CORMEDIX INC.

300 CONNELL DRIVE, SUITE 4200

(Street)

BERKELEY HEIGHTS

07922

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [ CRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/14/2024		M		3	A	$1.45	45,400	D
Common Stock	11/14/2024		M		8,169	A	$8.3	53,569	D
Common Stock	11/14/2024		M		9,888	A	$5.63	63,457	D
Common Stock	11/14/2024		M		34,467	A	$4.08	97,924	D
Common Stock	11/14/2024		M		62,500	A	$4.43	160,424	D
Common Stock	11/14/2024		M		25,000	A	$3.47	185,424	D
Common Stock⁽¹⁾	11/14/2024⁽¹⁾	⁽¹⁾	S⁽¹⁾		140,027⁽¹⁾	D⁽¹⁾	$11.1812⁽¹⁾	45,397⁽¹⁾	D⁽¹⁾	⁽¹⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy Common Stock)	$1.45	11/14/2024		M			3	⁽²⁾	03/19/2028	Common Stock	3	$0	53,997	D
Stock Option (Right to Buy Common Stock)	$8.3	11/14/2024		M			8,169	⁽³⁾	01/10/2029	Common Stock	8,169	$0	12,711	D
Stock Option (Right to Buy Common Stock)	$5.63	11/14/2024		M			9,888	⁽⁴⁾	05/11/2030	Common Stock	9,888	$0	27,612	D
Stock Option (Right to Buy Common Stock)	$4.08	11/14/2024		M			34,467	⁽⁵⁾	05/11/2030	Common Stock	34,467	$0	3,033	D
Stock Option (Right to Buy Common Stock)	$4.43	11/14/2024		M			62,500	⁽⁶⁾	01/14/2033	Common Stock	62,500	$0	62,500	D
Stock Option (Right to Buy Common Stock)	$3.47	11/14/2024		M			25,000	⁽⁷⁾	01/11/2034	Common Stock	25,000	$0	75,000	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $11.00 to $11.45. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

2. These options were granted 3/19/2018 and vested as follows: 37,200 vested over four years in four (4) equal installments on the first four anniversaries of 3/19/2018. The remaining options vested on the achievement of certain milestones. This option was previously reported as covering 186,000 shares but was adjusted to reflect a reverse stock split that occurred on March 26, 2019.

3. These options were granted 1/10/2019 and vested as follows: 35% of the options vest over time, with 25% vested on the grant date and 25% vesting on the first, second and third anniversaries of the grant date; and 65% of the options vest upon the achievement of certain milestones.

4. These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

5. These options were granted on 05/11/2020. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

6. These options were granted on 1/14/2023. These options vested 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant and will vest 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

7. These options were granted on 01/12/2024. These options vested 1/4 on the date of grant, and, subject to continued employment, will vest 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

	/s/ Elizabeth Hurlburt	11/18/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.